Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection

Claudia A. Kozinetz, Kathryn Royse, Sarah C. Graham, Xiaoying Yu, Jack Moye, Beatrice J. Selwyn, Michele R. Forman, Chantal Caviness

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The National Children’s Study (NCS) Harris County, Texas Study Center participated in the NCS Provider Based Sampling (PBS) substudy of the NCS Vanguard Phase pilot. As part of the hospital-based birth cohort component of the PBS substudy, we conducted a secondary data analysis to evaluate the proportion of postpartum women who consented to future biospecimen collection alone and to both future collection and use of residual birth biospecimens. In phase 1, 32 postpartum women at one hospital were asked to consent only to maternal future biospecimen collection. In phase 2, 40 other postpartum women from the same hospital were asked for an additional consent to use residual clinical biospecimens from the birth event that otherwise would be discarded, including cord blood and maternal blood and urine. Among 103 eligible women, a total of 72 participated. They were 28.3 ± 5.9 years old on average; 58 % were Hispanic; 63 % consented in English, and 37 % in Spanish; 39 % had some college education; 42 % were married; 60 % had an annual family income <$30,000; and 51 % were employed. In phase 1, 59 % consented to future biospecimen collection, and in phase 2, 95 % consented to both future collection and use of at least one residual birth biospecimen, with a difference between phases of 36 % [95 % CI 17–54 %]. Demographic characteristics did not differ among those who did and did not consent. Postpartum women were significantly more likely to grant consent for use of future and residual hospital-obtained biospecimens than future biospecimen collection alone.

Original languageEnglish (US)
Pages (from-to)153-158
Number of pages6
JournalJournal of Community Genetics
Volume7
Issue number2
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Postpartum Period
Parturition
Mothers
Fetal Blood
Hispanic Americans
Demography
Urine
Education

Keywords

  • Biospecimen
  • Consent
  • Postpartum
  • Residual

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection. / Kozinetz, Claudia A.; Royse, Kathryn; Graham, Sarah C.; Yu, Xiaoying; Moye, Jack; Selwyn, Beatrice J.; Forman, Michele R.; Caviness, Chantal.

In: Journal of Community Genetics, Vol. 7, No. 2, 01.04.2016, p. 153-158.

Research output: Contribution to journalArticle

Kozinetz, Claudia A. ; Royse, Kathryn ; Graham, Sarah C. ; Yu, Xiaoying ; Moye, Jack ; Selwyn, Beatrice J. ; Forman, Michele R. ; Caviness, Chantal. / Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection. In: Journal of Community Genetics. 2016 ; Vol. 7, No. 2. pp. 153-158.
@article{7157be31ae3e4932b6c99b5377f087be,
title = "Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection",
abstract = "The National Children’s Study (NCS) Harris County, Texas Study Center participated in the NCS Provider Based Sampling (PBS) substudy of the NCS Vanguard Phase pilot. As part of the hospital-based birth cohort component of the PBS substudy, we conducted a secondary data analysis to evaluate the proportion of postpartum women who consented to future biospecimen collection alone and to both future collection and use of residual birth biospecimens. In phase 1, 32 postpartum women at one hospital were asked to consent only to maternal future biospecimen collection. In phase 2, 40 other postpartum women from the same hospital were asked for an additional consent to use residual clinical biospecimens from the birth event that otherwise would be discarded, including cord blood and maternal blood and urine. Among 103 eligible women, a total of 72 participated. They were 28.3 ± 5.9 years old on average; 58 {\%} were Hispanic; 63 {\%} consented in English, and 37 {\%} in Spanish; 39 {\%} had some college education; 42 {\%} were married; 60 {\%} had an annual family income <$30,000; and 51 {\%} were employed. In phase 1, 59 {\%} consented to future biospecimen collection, and in phase 2, 95 {\%} consented to both future collection and use of at least one residual birth biospecimen, with a difference between phases of 36 {\%} [95 {\%} CI 17–54 {\%}]. Demographic characteristics did not differ among those who did and did not consent. Postpartum women were significantly more likely to grant consent for use of future and residual hospital-obtained biospecimens than future biospecimen collection alone.",
keywords = "Biospecimen, Consent, Postpartum, Residual",
author = "Kozinetz, {Claudia A.} and Kathryn Royse and Graham, {Sarah C.} and Xiaoying Yu and Jack Moye and Selwyn, {Beatrice J.} and Forman, {Michele R.} and Chantal Caviness",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s12687-016-0261-9",
language = "English (US)",
volume = "7",
pages = "153--158",
journal = "Journal of Community Genetics",
issn = "1868-310X",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection

AU - Kozinetz, Claudia A.

AU - Royse, Kathryn

AU - Graham, Sarah C.

AU - Yu, Xiaoying

AU - Moye, Jack

AU - Selwyn, Beatrice J.

AU - Forman, Michele R.

AU - Caviness, Chantal

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The National Children’s Study (NCS) Harris County, Texas Study Center participated in the NCS Provider Based Sampling (PBS) substudy of the NCS Vanguard Phase pilot. As part of the hospital-based birth cohort component of the PBS substudy, we conducted a secondary data analysis to evaluate the proportion of postpartum women who consented to future biospecimen collection alone and to both future collection and use of residual birth biospecimens. In phase 1, 32 postpartum women at one hospital were asked to consent only to maternal future biospecimen collection. In phase 2, 40 other postpartum women from the same hospital were asked for an additional consent to use residual clinical biospecimens from the birth event that otherwise would be discarded, including cord blood and maternal blood and urine. Among 103 eligible women, a total of 72 participated. They were 28.3 ± 5.9 years old on average; 58 % were Hispanic; 63 % consented in English, and 37 % in Spanish; 39 % had some college education; 42 % were married; 60 % had an annual family income <$30,000; and 51 % were employed. In phase 1, 59 % consented to future biospecimen collection, and in phase 2, 95 % consented to both future collection and use of at least one residual birth biospecimen, with a difference between phases of 36 % [95 % CI 17–54 %]. Demographic characteristics did not differ among those who did and did not consent. Postpartum women were significantly more likely to grant consent for use of future and residual hospital-obtained biospecimens than future biospecimen collection alone.

AB - The National Children’s Study (NCS) Harris County, Texas Study Center participated in the NCS Provider Based Sampling (PBS) substudy of the NCS Vanguard Phase pilot. As part of the hospital-based birth cohort component of the PBS substudy, we conducted a secondary data analysis to evaluate the proportion of postpartum women who consented to future biospecimen collection alone and to both future collection and use of residual birth biospecimens. In phase 1, 32 postpartum women at one hospital were asked to consent only to maternal future biospecimen collection. In phase 2, 40 other postpartum women from the same hospital were asked for an additional consent to use residual clinical biospecimens from the birth event that otherwise would be discarded, including cord blood and maternal blood and urine. Among 103 eligible women, a total of 72 participated. They were 28.3 ± 5.9 years old on average; 58 % were Hispanic; 63 % consented in English, and 37 % in Spanish; 39 % had some college education; 42 % were married; 60 % had an annual family income <$30,000; and 51 % were employed. In phase 1, 59 % consented to future biospecimen collection, and in phase 2, 95 % consented to both future collection and use of at least one residual birth biospecimen, with a difference between phases of 36 % [95 % CI 17–54 %]. Demographic characteristics did not differ among those who did and did not consent. Postpartum women were significantly more likely to grant consent for use of future and residual hospital-obtained biospecimens than future biospecimen collection alone.

KW - Biospecimen

KW - Consent

KW - Postpartum

KW - Residual

UR - http://www.scopus.com/inward/record.url?scp=84957702648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957702648&partnerID=8YFLogxK

U2 - 10.1007/s12687-016-0261-9

DO - 10.1007/s12687-016-0261-9

M3 - Article

VL - 7

SP - 153

EP - 158

JO - Journal of Community Genetics

JF - Journal of Community Genetics

SN - 1868-310X

IS - 2

ER -